State KY
Clinical Trials in Kentucky
Kentucky is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kentucky and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 163 actively recruiting studies with Kentucky sites out of 163 registered in total. The busiest research areas in Kentucky are Colorectal Cancer, Ovarian Cancer, Hypertension. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of Louisville, SWOG Cancer Research Network. By stage, Kentucky trials break down as Phase 1 (21), Phase 2 (49), Phase 3 (59), Phase 4 (8).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Kentucky
Frequently Asked Questions — Clinical Trials in Kentucky
How many clinical trials are currently recruiting in Kentucky?
ClinicalMetric currently tracks 163 actively recruiting clinical trials with at least one location in Kentucky. The total number of registered studies—including active but not currently enrolling trials—is 163. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kentucky?
Kentucky hosts clinical trials across a broad range of medical conditions, including Colorectal Cancer, Ovarian Cancer, Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kentucky serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kentucky?
To join a clinical trial in Kentucky, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kentucky maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kentucky
NCT06581328 Phase 4
Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in t...
Condition
Ulcerative Colitis
Enrollment
400 pts
Location
United States
Sponsor
Takeda
NCT05659381 Phase 3
Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary P...
Condition
Stage III Ovarian Cancer
Enrollment
220 pts
Location
United States
Sponsor
GOG Foundation
NCT04172532 Phase 1, Phase 2
Recruiting
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
92 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05034432 Phase 4
Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventri...
Condition
Arrythmia
Enrollment
100 pts
Location
United States
Sponsor
University of Rochester
NCT06543407 N/A
Recruiting
Harm Reduction for Smokers With Mental Illness
Condition
Tobacco Dependence
Enrollment
250 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
NCT06109272 Phase 2, Phase 3
Recruiting
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Li...
Condition
Hepatocellular Carcinoma
Enrollment
660 pts
Location
United States, France, Italy
Sponsor
AbbVie
NCT05263206 Phase 3
Recruiting
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Partici...
Condition
Pruritus
Enrollment
284 pts
Location
United States, Argentina, Canada
Sponsor
Sanofi
NCT07449702 Phase 2
Recruiting
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Condition
Plaque Psoriasis
Enrollment
240 pts
Location
United States, Canada
Sponsor
Oruka Therapeutics, Inc.
NCT04504136 N/A
Recruiting
Regulation of Mucosal Healing in Inflammatory Bowel Disease
Condition
Inflammatory Bowel Diseases
Enrollment
60 pts
Location
United States
Sponsor
Terrence A Barrett
NCT07165132 Phase 1
Recruiting
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Condition
GEP-NET
Enrollment
104 pts
Location
United States, Canada
Sponsor
RayzeBio, Inc.
NCT06311214 Phase 2
Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing fo...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
500 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07690371 Phase 3
Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age W...
Condition
Moderate-to-Severe Atopic Dermatitis
Enrollment
510 pts
Location
United States
Sponsor
Nektar Therapeutics
NCT00682032 N/A
Recruiting
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
Condition
Non Small Cell Lung Cancer
Enrollment
300 pts
Location
United States
Sponsor
University of Louisville
NCT04165798 N/A
Recruiting
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Eithe...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
1,065 pts
Location
United States, Hungary, Israel
Sponsor
Merck Sharp & Dohme LLC
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participant...
Condition
B-cell Malignancy
Enrollment
645 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT03150693 Phase 3
Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With N...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
303 pts
Location
United States, Canada
Sponsor
Alliance for Clinical Trials i
NCT06998940 Phase 3
Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Adva...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
94 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04715178 N/A
Recruiting
Beat Childhood Cancer Specimen Banking and Data Registry
Condition
Pediatric Cancer
Enrollment
1,000 pts
Location
United States
Sponsor
Giselle Sholler
NCT05943535 Phase 3
Recruiting
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progre...
Condition
Progressive Pulmonary Fibrosis
Enrollment
698 pts
Location
United States, Argentina, Australia
Sponsor
United Therapeutics
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
NCT06008197 Phase 3
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mort...
Condition
Heart Failure
Enrollment
5,200 pts
Location
United States, Argentina, Australia
Sponsor
Colorado Prevention Center
NCT07091617 N/A
Recruiting
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing ...
Condition
Miscellaneous Neoplasm, Nos
Enrollment
535 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology